TRICIA JACKSON: Open Payments
NPI 1366932766 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $151 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 6 | $122 |
| ABBVIE INC. | 4 | $65 |
| Axsome Therapeutics, Inc. | 4 | $58 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
| Verona Pharma, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: ZURZUVAE, Auvelity, FANAPT, Ohtuvayre, TRELEGY ELLIPTA, MOUNJARO, UBRELVY, VRAYLAR.
Industry payments across KY — which companies pay providers there.
